2-(4-morpholinyl)-4-methylpent-1-ene | 66598-23-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: 2-(4-morpholinyl)-4-methylpent-1-ene
• 英文别名: N-(4-Methyl-1-penten-2-yl)morpholine；2-morpholino-4-methylpentene；4-(1-isobutyl-vinyl)-morpholine；2-Morpholino-4-methyl-penten-(1)；4-Morpholino-2-methyl-penten-(4)；2-Morpholino-4-methyl-penten；4-(4-Methylpent-1-en-2-yl)morpholine
• CAS: 66598-23-0
• 化学式: C₁₀H₁₉NO
• 分子量: 169.267
• InChiKey: QSQXRJXFHOPABI-UHFFFAOYSA-N

物化性质

• 沸点：
  76-77 °C(Press: 3 Torr)
• 密度：
  0.919±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(4-morpholinyl)-4-methylpent-1-ene 在 甲酸 作用下， 反应 2.0h， 以75%的产率得到4-(1,3-二甲基-丁基)-吗啉
  参考文献：
  名称：

  Nilsson, Asa; Carlson, Rolf, Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry, 1985, vol. 39, # 3, p. 187 - 190

  摘要：

  DOI：

文献信息

• N2-(2-METHOXYPHENYL)PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION OR TREATMENT CONTAINING SAME AS ACTIVE INGREDIENT
  申请人：KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY

  公开号：US20180111905A1

  公开（公告）日：2018-04-26

  The present invention relates to a N2-(2-methoxyphenyl)pyrimidine derivative, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of cancer comprising the same as an active ingredient. The N2-(2-methoxyphenyl)pyrimidine derivative, the optical isomer thereof, or the pharmaceutically acceptable salt thereof of the present invention is very effective in suppressing anaplastic lymphoma kinase (ALK) activity and as a result it can improve the effectiveness of treatment on cancer cells having anaplastic lymphoma kinase (ALK) fusion proteins such as EML4-ALK and NPM-ALK, so that it can be effectively used as a pharmaceutical composition for preventing or treating cancer.

  本发明涉及一种N2-(2-甲氧基苯基)嘧啶衍生物，其制备方法，以及包含其作为活性成分的用于预防或治疗癌症的药物组合物。本发明的N2-(2-甲氧基苯基)嘧啶衍生物，其光学异构体，或其药学上可接受的盐对抑制间变性淋巴瘤激酶（ALK）活性非常有效，从而可以提高对具有间变性淋巴瘤激酶（ALK）融合蛋白如EML4-ALK和NPM-ALK的癌细胞的治疗效果，因此可以有效地用作预防或治疗癌症的药物组合物。
• Phthalazines. XV. Ring transformation of phthalazines into naphthalenes by means of inverse-electron-demand Diels-Alder reaction.
  作者：Etsuo OISHI、Naokata TAIDO、Ken-ichi IWAMOTO、Akira MIYASHITA、Takeo HIGASHINO

  DOI：10.1248/cpb.38.3268

  日期：——

  The 1-substituted phthalazines 6 underwent inverse-electron-demand Diels-Alder reaction with the enamines 3 and ynamines 9, resulting in the formation of 1-substituted naphthalenes.Thus, 1-phthalazinecarbonitrile (6b) reacted with 3a-i to give the corresponding 1-naphthonitriles 7a-e, g, h and 2, 3-kihydro-1-naphthonitriles 8f, i, respectively. Similarly, reaction of 1-(methylsulfonyl)phthalazine (6c) with 3a, b, d, f gave the corresponding 1-(methylsulfonyl)naphthalenes 10a, b, d and 1-(methylsulfonyl)-2, 3-dihydronaphthalene 11f. Furthermore, 1-methylthio- (6e), 1-phenyl- (6f), 1-methyl-(6b), 1-chlorophthalazines (6h) and phthalazine (6a) reacted with 3a to afford the corresponding 4-substituted 2, 3-dihydro-1H-benz[f]indenes 12e-h, a, respectively.A similar ring transformation was found to proceed between 1, 4-phthalazinedicarbonitrile (14) and 1-methyl-1H-indole (13), giving the benzo[b]carbazoledicarbonitrile (15).Compounds 6b and 6c also underwent inverse-electron-demand Diels-Alder reaction with the ynamines 9a, b to give the corresponding 1-cyano-16a, b and 1-(methylsulfonyl)naphthalenes 17a, b, respectively.

  因此，1-酞嗪甲腈（6b）与 3a-i 反应，分别得到相应的 1-萘甲腈 7a-e、g、h 和 2、3-基氢-1-萘甲腈 8f、i。同样，1-（甲磺酰基）酞嗪（6c）与 3a、b、d、f 反应，得到相应的 1-（甲磺酰基）萘 10a、b、d 和 1-（甲磺酰基）-2，3-二氢萘 11f。此外，1-甲硫基（6e）、1-苯基（6f）、1-甲基（6b）、1-氯酞嗪（6h）和酞嗪（6a）与 3a 反应，分别得到相应的 4-取代的 2，3-二氢-1H-苯并[f]茚 12e-h、a。化合物 6b 和 6c 还与亚萘胺 9a 和 b 发生了反电子需求的 Diels-Alder 反应，分别得到了相应的 1-氰基-16a、b 和 1-（甲磺酰基）萘 17a、b。
• Fusco,R. et al., Chemische Berichte, 1963, vol. 96, p. 802 - 812
  作者：Fusco,R. et al.

  DOI：——

  日期：——
• Cocco, Maria Teresa; Congiu, Cenzo; Maccioni, Antonio, Gazzetta Chimica Italiana, 1988, vol. 118, # 3, p. 187 - 192
  作者：Cocco, Maria Teresa、Congiu, Cenzo、Maccioni, Antonio、Plumitallo, Antonio

  DOI：——

  日期：——
• Bernard; Cocco; Maccioni, Farmaco, Edizione Scientifica, 1985, vol. 40, # 4, p. 259 - 271
  作者：Bernard、Cocco、Maccioni、Plumitallo

  DOI：——

  日期：——